(Alliance News) - Aptamer Group PLC said on Tuesday that it has extended its contract with Unilever PLC for the development of novel Optimer binders for use in deodorant products.
The York, England-based biotechnology firm will partner with Unilever, the London-based consumer goods firm, to continue its work in testing Optimer binders as active ingredients in deodorants.
Aptamer said the use of active ingredients like Optimer binders in deodorant products is "highly novel" and "holds the potential for enhanced efficacy for customer products". Optimer binders target the C-S Lyase bacterial enzyme, which is critical in the generation of auxiliary odour.
The contract follows successful laboratory tests of the Optimer binders, allowing the partnership to progress to planned in-vivo studies before the end of 2024.
Aptamer Chief Executive Officer Arron Tolley said: "The continued advancement of our Optimer binders in collaboration with Unilever is a significant milestone for Aptamer Group. With efficacy testing on the horizon, we are optimistic about bringing these binders to market in the coming years and look forward to discussing commercial opportunities with Unilever upon successful trial outcomes."
Aptamer Group share prices were up 8.7% to 0.25 pence each in London on Tuesday morning.
By Emily Parsons, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.


LONDON, July 1 (Reuters) - A rush of foreign bids for UK companies has put Britain on track to outstrip all previous records for dealmaking in 2026,...


* Thorne attracted strategic interest, including a bid from Haleon, sources say


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:


(Alliance News) - London's FTSE 100 hit a new all-time high on Wednesday shrugging off a hot UK inflation print and fresh falls among technology stock...


(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:


Talks at risk of ending with no deal *


Talks at risk of ending with no deal *


(Alliance News) - The FTSE 100 made steady progress on Wednesday, pushing back towards record highs, as hopes grew that the US Federal Reserve will lo...


(Alliance News) - Rolls-Royce Holding PLC's plan to power artificial intelligence with its small nuclear reactors could make it the UK's most valuable...




Q2 underlying net sales down 5.8% *